Medical Care
Global CAR-T Cell Immunotherapy Market Research Report 2025
- Nov 18, 25
- ID: 507430
- Pages: 79
- Figures: 77
- Views: 25
This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Immunotherapy.
The CAR-T Cell Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Bristol Myers Squibb
Johnson & Johnson (Legend Biotech)
Fosun Kairos
ISAO Bio
JW (Cayman) Therapeutics
CARsgen Therapeutics
Juventas Cell Therapy
Hrain Biotechnology Co
Segment by Type
Single Target
Multiple Targets
Segment by Source
Autologous
Allogeneic
Segment by Generation
First Generation
Second Generation
Third Generation
Fourth Generation
Segment by Application
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
High Grade B Cell Lymphoma
Myeloma
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Source etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cell Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The CAR-T Cell Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Bristol Myers Squibb
Johnson & Johnson (Legend Biotech)
Fosun Kairos
ISAO Bio
JW (Cayman) Therapeutics
CARsgen Therapeutics
Juventas Cell Therapy
Hrain Biotechnology Co
Segment by Type
Single Target
Multiple Targets
Segment by Source
Autologous
Allogeneic
Segment by Generation
First Generation
Second Generation
Third Generation
Fourth Generation
Segment by Application
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
High Grade B Cell Lymphoma
Myeloma
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Source etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cell Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Target
1.2.3 Multiple Targets
1.3 Market by Source
1.3.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.4 Market by Generation
1.4.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Generation: 2020 VS 2024 VS 2031
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.4.5 Fourth Generation
1.5 Market by Application
1.5.1 Global CAR-T Cell Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Relapsed or Refractory Mantle Cell Lymphoma (MCL)
1.5.3 High Grade B Cell Lymphoma
1.5.4 Myeloma
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Cell Immunotherapy Market Perspective (2020-2031)
2.2 Global CAR-T Cell Immunotherapy Growth Trends by Region
2.2.1 Global CAR-T Cell Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-T Cell Immunotherapy Historic Market Size by Region (2020-2025)
2.2.3 CAR-T Cell Immunotherapy Forecasted Market Size by Region (2026-2031)
2.3 CAR-T Cell Immunotherapy Market Dynamics
2.3.1 CAR-T Cell Immunotherapy Industry Trends
2.3.2 CAR-T Cell Immunotherapy Market Drivers
2.3.3 CAR-T Cell Immunotherapy Market Challenges
2.3.4 CAR-T Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Cell Immunotherapy Players by Revenue
3.1.1 Global Top CAR-T Cell Immunotherapy Players by Revenue (2020-2025)
3.1.2 Global CAR-T Cell Immunotherapy Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-T Cell Immunotherapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-T Cell Immunotherapy Revenue
3.4 Global CAR-T Cell Immunotherapy Market Concentration Ratio
3.4.1 Global CAR-T Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Immunotherapy Revenue in 2024
3.5 Global Key Players of CAR-T Cell Immunotherapy Head office and Area Served
3.6 Global Key Players of CAR-T Cell Immunotherapy, Product and Application
3.7 Global Key Players of CAR-T Cell Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Cell Immunotherapy Breakdown Data by Type
4.1 Global CAR-T Cell Immunotherapy Historic Market Size by Type (2020-2025)
4.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2026-2031)
5 CAR-T Cell Immunotherapy Breakdown Data by Application
5.1 Global CAR-T Cell Immunotherapy Historic Market Size by Application (2020-2025)
5.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-T Cell Immunotherapy Market Size (2020-2031)
6.2 North America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
6.4 North America CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Cell Immunotherapy Market Size (2020-2031)
7.2 Europe CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
7.4 Europe CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Cell Immunotherapy Market Size (2020-2031)
8.2 Asia-Pacific CAR-T Cell Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CAR-T Cell Immunotherapy Market Size (2020-2031)
9.2 Latin America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
9.4 Latin America CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Cell Immunotherapy Market Size (2020-2031)
10.2 Middle East & Africa CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences CAR-T Cell Immunotherapy Introduction
11.1.4 Gilead Sciences Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis CAR-T Cell Immunotherapy Introduction
11.2.4 Novartis Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Cell Immunotherapy Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Details
11.4.2 Johnson & Johnson (Legend Biotech) Business Overview
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Cell Immunotherapy Introduction
11.4.4 Johnson & Johnson (Legend Biotech) Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.4.5 Johnson & Johnson (Legend Biotech) Recent Development
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Details
11.5.2 Fosun Kairos Business Overview
11.5.3 Fosun Kairos CAR-T Cell Immunotherapy Introduction
11.5.4 Fosun Kairos Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.5.5 Fosun Kairos Recent Development
11.6 ISAO Bio
11.6.1 ISAO Bio Company Details
11.6.2 ISAO Bio Business Overview
11.6.3 ISAO Bio CAR-T Cell Immunotherapy Introduction
11.6.4 ISAO Bio Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.6.5 ISAO Bio Recent Development
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Details
11.7.2 JW (Cayman) Therapeutics Business Overview
11.7.3 JW (Cayman) Therapeutics CAR-T Cell Immunotherapy Introduction
11.7.4 JW (Cayman) Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.7.5 JW (Cayman) Therapeutics Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR-T Cell Immunotherapy Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Details
11.9.2 Juventas Cell Therapy Business Overview
11.9.3 Juventas Cell Therapy CAR-T Cell Immunotherapy Introduction
11.9.4 Juventas Cell Therapy Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.9.5 Juventas Cell Therapy Recent Development
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Details
11.10.2 Hrain Biotechnology Co Business Overview
11.10.3 Hrain Biotechnology Co CAR-T Cell Immunotherapy Introduction
11.10.4 Hrain Biotechnology Co Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.10.5 Hrain Biotechnology Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Target
1.2.3 Multiple Targets
1.3 Market by Source
1.3.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.4 Market by Generation
1.4.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Generation: 2020 VS 2024 VS 2031
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.4.5 Fourth Generation
1.5 Market by Application
1.5.1 Global CAR-T Cell Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Relapsed or Refractory Mantle Cell Lymphoma (MCL)
1.5.3 High Grade B Cell Lymphoma
1.5.4 Myeloma
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Cell Immunotherapy Market Perspective (2020-2031)
2.2 Global CAR-T Cell Immunotherapy Growth Trends by Region
2.2.1 Global CAR-T Cell Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-T Cell Immunotherapy Historic Market Size by Region (2020-2025)
2.2.3 CAR-T Cell Immunotherapy Forecasted Market Size by Region (2026-2031)
2.3 CAR-T Cell Immunotherapy Market Dynamics
2.3.1 CAR-T Cell Immunotherapy Industry Trends
2.3.2 CAR-T Cell Immunotherapy Market Drivers
2.3.3 CAR-T Cell Immunotherapy Market Challenges
2.3.4 CAR-T Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Cell Immunotherapy Players by Revenue
3.1.1 Global Top CAR-T Cell Immunotherapy Players by Revenue (2020-2025)
3.1.2 Global CAR-T Cell Immunotherapy Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-T Cell Immunotherapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-T Cell Immunotherapy Revenue
3.4 Global CAR-T Cell Immunotherapy Market Concentration Ratio
3.4.1 Global CAR-T Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Immunotherapy Revenue in 2024
3.5 Global Key Players of CAR-T Cell Immunotherapy Head office and Area Served
3.6 Global Key Players of CAR-T Cell Immunotherapy, Product and Application
3.7 Global Key Players of CAR-T Cell Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Cell Immunotherapy Breakdown Data by Type
4.1 Global CAR-T Cell Immunotherapy Historic Market Size by Type (2020-2025)
4.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2026-2031)
5 CAR-T Cell Immunotherapy Breakdown Data by Application
5.1 Global CAR-T Cell Immunotherapy Historic Market Size by Application (2020-2025)
5.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-T Cell Immunotherapy Market Size (2020-2031)
6.2 North America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
6.4 North America CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Cell Immunotherapy Market Size (2020-2031)
7.2 Europe CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
7.4 Europe CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Cell Immunotherapy Market Size (2020-2031)
8.2 Asia-Pacific CAR-T Cell Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CAR-T Cell Immunotherapy Market Size (2020-2031)
9.2 Latin America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
9.4 Latin America CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Cell Immunotherapy Market Size (2020-2031)
10.2 Middle East & Africa CAR-T Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences CAR-T Cell Immunotherapy Introduction
11.1.4 Gilead Sciences Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis CAR-T Cell Immunotherapy Introduction
11.2.4 Novartis Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Cell Immunotherapy Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Details
11.4.2 Johnson & Johnson (Legend Biotech) Business Overview
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Cell Immunotherapy Introduction
11.4.4 Johnson & Johnson (Legend Biotech) Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.4.5 Johnson & Johnson (Legend Biotech) Recent Development
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Details
11.5.2 Fosun Kairos Business Overview
11.5.3 Fosun Kairos CAR-T Cell Immunotherapy Introduction
11.5.4 Fosun Kairos Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.5.5 Fosun Kairos Recent Development
11.6 ISAO Bio
11.6.1 ISAO Bio Company Details
11.6.2 ISAO Bio Business Overview
11.6.3 ISAO Bio CAR-T Cell Immunotherapy Introduction
11.6.4 ISAO Bio Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.6.5 ISAO Bio Recent Development
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Details
11.7.2 JW (Cayman) Therapeutics Business Overview
11.7.3 JW (Cayman) Therapeutics CAR-T Cell Immunotherapy Introduction
11.7.4 JW (Cayman) Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.7.5 JW (Cayman) Therapeutics Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR-T Cell Immunotherapy Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Details
11.9.2 Juventas Cell Therapy Business Overview
11.9.3 Juventas Cell Therapy CAR-T Cell Immunotherapy Introduction
11.9.4 Juventas Cell Therapy Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.9.5 Juventas Cell Therapy Recent Development
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Details
11.10.2 Hrain Biotechnology Co Business Overview
11.10.3 Hrain Biotechnology Co CAR-T Cell Immunotherapy Introduction
11.10.4 Hrain Biotechnology Co Revenue in CAR-T Cell Immunotherapy Business (2020-2025)
11.10.5 Hrain Biotechnology Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Single Target
Table 3. Key Players of Multiple Targets
Table 4. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Autologous
Table 6. Key Players of Allogeneic
Table 7. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Generation (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of First Generation
Table 9. Key Players of Second Generation
Table 10. Key Players of Third Generation
Table 11. Key Players of Fourth Generation
Table 12. Global CAR-T Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Global CAR-T Cell Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global CAR-T Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global CAR-T Cell Immunotherapy Market Share by Region (2020-2025)
Table 16. Global CAR-T Cell Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global CAR-T Cell Immunotherapy Market Share by Region (2026-2031)
Table 18. CAR-T Cell Immunotherapy Market Trends
Table 19. CAR-T Cell Immunotherapy Market Drivers
Table 20. CAR-T Cell Immunotherapy Market Challenges
Table 21. CAR-T Cell Immunotherapy Market Restraints
Table 22. Global CAR-T Cell Immunotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 23. Global CAR-T Cell Immunotherapy Market Share by Players (2020-2025)
Table 24. Global Top CAR-T Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapy as of 2024)
Table 25. Ranking of Global Top CAR-T Cell Immunotherapy Companies by Revenue (US$ Million) in 2024
Table 26. Global 5 Largest Players Market Share by CAR-T Cell Immunotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 27. Global Key Players of CAR-T Cell Immunotherapy, Headquarters and Area Served
Table 28. Global Key Players of CAR-T Cell Immunotherapy, Product and Application
Table 29. Global Key Players of CAR-T Cell Immunotherapy, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR-T Cell Immunotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 32. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2020-2025)
Table 33. Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 34. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2026-2031)
Table 35. Global CAR-T Cell Immunotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 36. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2020-2025)
Table 37. Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 38. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2026-2031)
Table 39. North America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. North America CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 41. North America CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 42. Europe CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Europe CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Europe CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Asia-Pacific CAR-T Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 46. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 47. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 48. Latin America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Latin America CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 50. Latin America CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 51. Middle East & Africa CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 53. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 54. Gilead Sciences Company Details
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences CAR-T Cell Immunotherapy Product
Table 57. Gilead Sciences Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis CAR-T Cell Immunotherapy Product
Table 62. Novartis Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol Myers Squibb Company Details
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb CAR-T Cell Immunotherapy Product
Table 67. Bristol Myers Squibb Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 68. Bristol Myers Squibb Recent Development
Table 69. Johnson & Johnson (Legend Biotech) Company Details
Table 70. Johnson & Johnson (Legend Biotech) Business Overview
Table 71. Johnson & Johnson (Legend Biotech) CAR-T Cell Immunotherapy Product
Table 72. Johnson & Johnson (Legend Biotech) Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 73. Johnson & Johnson (Legend Biotech) Recent Development
Table 74. Fosun Kairos Company Details
Table 75. Fosun Kairos Business Overview
Table 76. Fosun Kairos CAR-T Cell Immunotherapy Product
Table 77. Fosun Kairos Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 78. Fosun Kairos Recent Development
Table 79. ISAO Bio Company Details
Table 80. ISAO Bio Business Overview
Table 81. ISAO Bio CAR-T Cell Immunotherapy Product
Table 82. ISAO Bio Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 83. ISAO Bio Recent Development
Table 84. JW (Cayman) Therapeutics Company Details
Table 85. JW (Cayman) Therapeutics Business Overview
Table 86. JW (Cayman) Therapeutics CAR-T Cell Immunotherapy Product
Table 87. JW (Cayman) Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 88. JW (Cayman) Therapeutics Recent Development
Table 89. CARsgen Therapeutics Company Details
Table 90. CARsgen Therapeutics Business Overview
Table 91. CARsgen Therapeutics CAR-T Cell Immunotherapy Product
Table 92. CARsgen Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 93. CARsgen Therapeutics Recent Development
Table 94. Juventas Cell Therapy Company Details
Table 95. Juventas Cell Therapy Business Overview
Table 96. Juventas Cell Therapy CAR-T Cell Immunotherapy Product
Table 97. Juventas Cell Therapy Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 98. Juventas Cell Therapy Recent Development
Table 99. Hrain Biotechnology Co Company Details
Table 100. Hrain Biotechnology Co Business Overview
Table 101. Hrain Biotechnology Co CAR-T Cell Immunotherapy Product
Table 102. Hrain Biotechnology Co Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 103. Hrain Biotechnology Co Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. CAR-T Cell Immunotherapy Picture
Figure 2. Global CAR-T Cell Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Cell Immunotherapy Market Share by Type: 2024 VS 2031
Figure 4. Single Target Features
Figure 5. Multiple Targets Features
Figure 6. Global CAR-T Cell Immunotherapy Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 7. Autologous Features
Figure 8. Allogeneic Features
Figure 9. Global CAR-T Cell Immunotherapy Market Size Comparison by Generation (2020-2031) & (US$ Million)
Figure 10. First Generation Features
Figure 11. Second Generation Features
Figure 12. Third Generation Features
Figure 13. Fourth Generation Features
Figure 14. Global CAR-T Cell Immunotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 15. Global CAR-T Cell Immunotherapy Market Share by Application: 2024 VS 2031
Figure 16. Relapsed or Refractory Mantle Cell Lymphoma (MCL) Case Studies
Figure 17. High Grade B Cell Lymphoma Case Studies
Figure 18. Myeloma Case Studies
Figure 19. Others Case Studies
Figure 20. CAR-T Cell Immunotherapy Report Years Considered
Figure 21. Global CAR-T Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global CAR-T Cell Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global CAR-T Cell Immunotherapy Market Share by Region: 2024 VS 2031
Figure 24. Global CAR-T Cell Immunotherapy Market Share by Players in 2024
Figure 25. Global CAR-T Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by CAR-T Cell Immunotherapy Revenue in 2024
Figure 27. North America CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 29. United States CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 33. Germany CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Ireland CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific CAR-T Cell Immunotherapy Market Share by Region (2020-2031)
Figure 41. China CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia & New Zealand CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 49. Mexico CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 53. Israel CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Gilead Sciences Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 59. Johnson & Johnson (Legend Biotech) Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 60. Fosun Kairos Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 61. ISAO Bio Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 62. JW (Cayman) Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 63. CARsgen Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 64. Juventas Cell Therapy Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 65. Hrain Biotechnology Co Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Single Target
Table 3. Key Players of Multiple Targets
Table 4. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Autologous
Table 6. Key Players of Allogeneic
Table 7. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Generation (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of First Generation
Table 9. Key Players of Second Generation
Table 10. Key Players of Third Generation
Table 11. Key Players of Fourth Generation
Table 12. Global CAR-T Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Global CAR-T Cell Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global CAR-T Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global CAR-T Cell Immunotherapy Market Share by Region (2020-2025)
Table 16. Global CAR-T Cell Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global CAR-T Cell Immunotherapy Market Share by Region (2026-2031)
Table 18. CAR-T Cell Immunotherapy Market Trends
Table 19. CAR-T Cell Immunotherapy Market Drivers
Table 20. CAR-T Cell Immunotherapy Market Challenges
Table 21. CAR-T Cell Immunotherapy Market Restraints
Table 22. Global CAR-T Cell Immunotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 23. Global CAR-T Cell Immunotherapy Market Share by Players (2020-2025)
Table 24. Global Top CAR-T Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapy as of 2024)
Table 25. Ranking of Global Top CAR-T Cell Immunotherapy Companies by Revenue (US$ Million) in 2024
Table 26. Global 5 Largest Players Market Share by CAR-T Cell Immunotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 27. Global Key Players of CAR-T Cell Immunotherapy, Headquarters and Area Served
Table 28. Global Key Players of CAR-T Cell Immunotherapy, Product and Application
Table 29. Global Key Players of CAR-T Cell Immunotherapy, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR-T Cell Immunotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 32. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2020-2025)
Table 33. Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 34. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2026-2031)
Table 35. Global CAR-T Cell Immunotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 36. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2020-2025)
Table 37. Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 38. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2026-2031)
Table 39. North America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. North America CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 41. North America CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 42. Europe CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Europe CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Europe CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Asia-Pacific CAR-T Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 46. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 47. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 48. Latin America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Latin America CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 50. Latin America CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 51. Middle East & Africa CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 53. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 54. Gilead Sciences Company Details
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences CAR-T Cell Immunotherapy Product
Table 57. Gilead Sciences Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis CAR-T Cell Immunotherapy Product
Table 62. Novartis Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol Myers Squibb Company Details
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb CAR-T Cell Immunotherapy Product
Table 67. Bristol Myers Squibb Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 68. Bristol Myers Squibb Recent Development
Table 69. Johnson & Johnson (Legend Biotech) Company Details
Table 70. Johnson & Johnson (Legend Biotech) Business Overview
Table 71. Johnson & Johnson (Legend Biotech) CAR-T Cell Immunotherapy Product
Table 72. Johnson & Johnson (Legend Biotech) Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 73. Johnson & Johnson (Legend Biotech) Recent Development
Table 74. Fosun Kairos Company Details
Table 75. Fosun Kairos Business Overview
Table 76. Fosun Kairos CAR-T Cell Immunotherapy Product
Table 77. Fosun Kairos Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 78. Fosun Kairos Recent Development
Table 79. ISAO Bio Company Details
Table 80. ISAO Bio Business Overview
Table 81. ISAO Bio CAR-T Cell Immunotherapy Product
Table 82. ISAO Bio Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 83. ISAO Bio Recent Development
Table 84. JW (Cayman) Therapeutics Company Details
Table 85. JW (Cayman) Therapeutics Business Overview
Table 86. JW (Cayman) Therapeutics CAR-T Cell Immunotherapy Product
Table 87. JW (Cayman) Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 88. JW (Cayman) Therapeutics Recent Development
Table 89. CARsgen Therapeutics Company Details
Table 90. CARsgen Therapeutics Business Overview
Table 91. CARsgen Therapeutics CAR-T Cell Immunotherapy Product
Table 92. CARsgen Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 93. CARsgen Therapeutics Recent Development
Table 94. Juventas Cell Therapy Company Details
Table 95. Juventas Cell Therapy Business Overview
Table 96. Juventas Cell Therapy CAR-T Cell Immunotherapy Product
Table 97. Juventas Cell Therapy Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 98. Juventas Cell Therapy Recent Development
Table 99. Hrain Biotechnology Co Company Details
Table 100. Hrain Biotechnology Co Business Overview
Table 101. Hrain Biotechnology Co CAR-T Cell Immunotherapy Product
Table 102. Hrain Biotechnology Co Revenue in CAR-T Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 103. Hrain Biotechnology Co Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. CAR-T Cell Immunotherapy Picture
Figure 2. Global CAR-T Cell Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Cell Immunotherapy Market Share by Type: 2024 VS 2031
Figure 4. Single Target Features
Figure 5. Multiple Targets Features
Figure 6. Global CAR-T Cell Immunotherapy Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 7. Autologous Features
Figure 8. Allogeneic Features
Figure 9. Global CAR-T Cell Immunotherapy Market Size Comparison by Generation (2020-2031) & (US$ Million)
Figure 10. First Generation Features
Figure 11. Second Generation Features
Figure 12. Third Generation Features
Figure 13. Fourth Generation Features
Figure 14. Global CAR-T Cell Immunotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 15. Global CAR-T Cell Immunotherapy Market Share by Application: 2024 VS 2031
Figure 16. Relapsed or Refractory Mantle Cell Lymphoma (MCL) Case Studies
Figure 17. High Grade B Cell Lymphoma Case Studies
Figure 18. Myeloma Case Studies
Figure 19. Others Case Studies
Figure 20. CAR-T Cell Immunotherapy Report Years Considered
Figure 21. Global CAR-T Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global CAR-T Cell Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global CAR-T Cell Immunotherapy Market Share by Region: 2024 VS 2031
Figure 24. Global CAR-T Cell Immunotherapy Market Share by Players in 2024
Figure 25. Global CAR-T Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by CAR-T Cell Immunotherapy Revenue in 2024
Figure 27. North America CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 29. United States CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 33. Germany CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Ireland CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific CAR-T Cell Immunotherapy Market Share by Region (2020-2031)
Figure 41. China CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia & New Zealand CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 49. Mexico CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa CAR-T Cell Immunotherapy Market Share by Country (2020-2031)
Figure 53. Israel CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE CAR-T Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Gilead Sciences Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 59. Johnson & Johnson (Legend Biotech) Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 60. Fosun Kairos Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 61. ISAO Bio Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 62. JW (Cayman) Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 63. CARsgen Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 64. Juventas Cell Therapy Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 65. Hrain Biotechnology Co Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232